| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 85.935 | 75.105 | 74.933 | 79.361 | 83.268 | 135.491 | 107.464 | 85.402 | 108.059 | 136.089 |
| Total Income - EUR | 85.952 | 78.725 | 84.813 | 80.837 | 83.365 | 138.035 | 119.874 | 99.394 | 108.273 | 142.031 |
| Total Expenses - EUR | 84.865 | 77.562 | 83.144 | 78.492 | 81.767 | 114.025 | 107.007 | 98.444 | 95.776 | 115.080 |
| Gross Profit/Loss - EUR | 1.087 | 1.164 | 1.669 | 2.345 | 1.598 | 24.009 | 12.867 | 950 | 12.497 | 26.951 |
| Net Profit/Loss - EUR | 154 | 377 | 394 | 1.536 | 763 | 22.989 | 11.972 | 190 | 11.659 | 24.040 |
| Employees | 5 | 5 | 5 | 4 | 3 | 4 | 4 | 4 | 4 | 4 |
Check the financial reports for the company - Medmark Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 20.627 | 25.534 | 15.477 | 9.737 | 5.533 | 28.079 | 42.411 | 34.797 | 26.609 | 13.872 |
| Current Assets | 21.506 | 18.028 | 20.891 | 22.232 | 22.276 | 35.166 | 40.014 | 24.042 | 32.530 | 36.152 |
| Inventories | 13.581 | 13.964 | 13.569 | 17.406 | 16.628 | 20.520 | 19.126 | 16.936 | 15.148 | 16.145 |
| Receivables | 5.050 | 3.535 | 6.741 | 3.275 | 5.408 | 5.100 | 8.390 | 5.206 | 13.026 | 18.800 |
| Cash | 2.875 | 529 | 581 | 1.551 | 241 | 9.546 | 12.498 | 1.901 | 4.356 | 1.207 |
| Shareholders Funds | 2.685 | 3.034 | 3.377 | 4.851 | 5.521 | 28.404 | 39.747 | 37.926 | 44.305 | 37.003 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 39.448 | 40.528 | 32.991 | 27.118 | 22.289 | 34.975 | 42.678 | 20.914 | 14.834 | 13.021 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Medmark Srl